Skip to main content

Table 1 Characteristics of lung cancer cases and healthy controls

From: Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene

Category

Group

Cases (n = 635)

Controls

  

LUCY-study

(n = 472)

HLC-study

(n = 163)

KORA-study

(n = 1300)

gender

men

66% (310)

59% (96)

63% (819)

 

women

34% (162)

41% (67)

37% (481)

age at diagnosis (mean ± SD)

men

45.4 ± 4.1

45.4 ± 3.7

45.2 ± 4.3

 

women

44.5 ± 4.6

45.1 ± 4.6

44.7 ± 4.7

age at diagnosis (men)

≤ 40 years

13% (40)

11% (11)

14% (116)

 

41–45 years

32% (99)

33% (32)

31% (251)

 

46–50 years

55% (171)

55% (53)

55% (451)

age at diagnosis (women)

≤ 40 years

17% (28)

16% (11)

17% (83)

 

41–45 years

31% (51)

25% (17)

30% (144)

 

46–50 years

51% (83)

58% (39)

53% (255)

LC subtypes (men)

NSCLC-Adenocarcinoma

26% (81)

35% (34)

 
 

other NSCLC

40% (125)

43% (41)

 
 

SCLC

26% (81)

20% (19)

 
 

other types

7% (22)

2% (2)

 

LC subtypes (women)

NSCLC-Adenocarcinoma

44% (71)

54% (36)

 
 

other NSCLC

22% (36)

24% (16)

 
 

SCLC

25% (41)

16% (11)

 
 

other types

9% (14)

6% (4)

 

smoking exposure (packyears)

minimally exposed (0–10)

12% (57)

13% (21)

54% (712)

 

lightly exposed (11–20)

17% (81)

8% (13)

14% (178)

 

moderately exposed (21–30)

31% (144)

20% (33)

15% (188)

 

highly exposed (31++)

39% (186)

52% (85)

15% (192)

 

unknown

0.9% (4)

7% (11)

2% (30)

MDM2 SNP309 genotypes*

TT

42% (199)

44% (71)

42% (547)

 

TG

47% (222)

44% (71)

46% (598)

 

GG

10% (49)

13% (21)

12% (149)

 

unknown

0.3% (2)

--

0.5% (6)

mean age at diagnosis (95% CI)

TT

45.1 (44.5–45.7)

44.8 (43.7–45.8)

 
 

TG

45.3 (44.7–45.8)

45.6 (44.7–46.5)

 
 

GG

44.6 (43.3–45.9)

45.9 (44.2–47.6)

 
  1. LUCY-study: Lung Cancer in the Young study; HLC-Study: Heidelberg lung cancer study; Other NSCLC = other non small cell lung cancers (NSCLC excluding adenocarcinoma), SCLC = small cell lung cancer, other types = other kinds of lung cancer